Teladoc Health Inc.

NYSE: TDOC · Real-Time Price · USD
7.50
0.20 (2.74%)
At close: Aug 15, 2025, 3:59 PM
7.52
0.20%
After-hours: Aug 15, 2025, 07:58 PM EDT

Teladoc Health Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-32.66M -93.01M -48.41M -33.28M -837.67M -81.89M -28.89M -57.07M -65.18M -69.23M -3.81B -73.48M -3.1B -6.67B -10.98M -84.34M -133.82M -199.65M
Depreciation & Amortization
86.98M 90.17M 91.67M 91.81M 98.85M 100.5M 101.48M 97.49M 78.83M 73.52M 78.88M 65.43M 63.45M 62.88M 57.03M 55.07M 55.09M 52.43M
Stock-Based Compensation
22.34M 25.16M 27.47M 34.05M 42.11M 42.33M 46.82M 52.96M 55.73M 46.04M 50.75M 55.66M 51M 60.44M 61.62M 71.7M 82.97M 86.3M
Other Working Capital
n/a -44.09M 20.73M 28.56M -20.03M -45.08M -2.91M -2.19M 37.08M -30M 1.26M 34.23M 6.82M -58.31M 11.66M 17.26M -349K -43.08M
Other Non-Cash Items
21.97M 20.46M 6.18M 3.91M 1.02B 251.65M -4.96M 3.42M 2.95M 6.36M 3.78B 7.52M 3.03B 6.61B 16.14M 18.95M 48.47M 25.55M
Deferred Income Tax
-7.21M -26.86M -1.76M -757K 2.97M -1.6M 4.75M -3.1M -3.2M -355K -1.9M -3.41M -209K -2.32M -49.61M 7.59M -3.18M 87M
Change in Working Capital
n/a n/a 10.74M 14.44M -9.59M -51.91M 10.87M 11.9M 32.05M -43.18M -36.22M 11.29M 47.59M -83.63M 9.03M 7.62M 2.69M -69.66M
Operating Cash Flow
91.43M 15.92M 85.9M 110.17M 88.68M 8.92M 130.08M 105.6M 101.18M 13.16M 65.55M 63.02M 92.47M -31.75M 83.21M 76.59M 52.22M -18.03M
Capital Expenditures
-1.27M -2.73M -29.64M -31.15M -27.75M -35.51M -36.51M -37.65M -36.57M -45.62M -53.89M -43.2M -44.84M -30.83M -22.92M -15.1M -12.65M -13.26M
Cash Acquisitions
-694K -64.61M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -2.72M -19.61M -415K -55.92M
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 10.9M n/a 12.65M -11.14M
Sales Maturities Of Investments
740K n/a n/a n/a n/a n/a n/a n/a n/a n/a -2.51M 2.51M n/a n/a -66.8M n/a 10.9M 50M
Other Investing Acitivies
-58.47M -55.93M -23.51M -89.75M -25.84M -34.36M 1K -31.85M -34.67M -43.26M 2.51M -750K -42.3M 3.26M 61.47M -13.89M -12.65M 14.29M
Investing Cash Flow
-59.7M -123.27M -29.64M -31.15M -27.75M -35.51M -36.51M -37.65M -36.57M -45.62M -53.89M -41.45M -44.84M -27.57M -20.07M -34.71M -2.17M -16.03M
Debt Repayment
-550.63M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.18M -923K 588K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a -278K n/a n/a n/a n/a n/a -313K n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-549.93M 769K 2.06M -259K 3.81M 1.75M -1.77M 5.07M 4.21M 3.35M 4.38M 634K -1.33M 2.82M 6.63M 1.96M 12.29M 21.59M
Financial Cash Flow
-549.93M 769K 2.06M 698K 3.81M 1.75M -1.77M 5.07M 4.21M 3.35M 4.38M 634K -1.33M 2.82M 6.63M 784K 11.36M 22.18M
Net Cash Flow
-513.71M -105M 54.46M 81.48M 64.45M -25.74M 93.15M 71.83M 70.12M -29.6M 18.55M 18.47M 44.72M -57.04M 69.65M 40.1M 63.62M -13.22M
Free Cash Flow
90.16M 13.19M 56.26M 79.03M 60.94M -26.59M 93.58M 67.95M 64.61M -32.47M 11.66M 19.82M 47.63M -62.58M 60.29M 61.49M 39.56M -31.29M